Hemolytic disease of the newborn

Skip Navigation

Hemolytic disease of the newborn (also called erythroblastosis fetalis) is a serious condition that may occur when the blood types of a mother and her baby do not match. Substances (antibodies) in the mother's blood cross the placenta and may destroy the red blood cells of the fetus.

After birth, a baby with hemolytic disease may be treated with a blood transfusion.




The Health Encyclopedia contains general health information. Not all treatments or services described are covered benefits for Kaiser Permanente members or offered as services by Kaiser Permanente. For a list of covered benefits, please refer to your Evidence of Coverage or Summary Plan Description. For recommended treatments, please consult with your health care provider.